{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:03:48Z","timestamp":1791518628579,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Agence Nationale pour la Recherche"},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002602","name":"American Society for Laser Medicine and Surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002602","id-type":"DOI","asserted-by":"publisher"}]},{"name":"university hospital of Lille"},{"DOI":"10.13039\/100015872","name":"University of Lille","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11060-021-03718-6","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T08:02:54Z","timestamp":1616227374000},"page":"501-514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial"],"prefix":"10.1007","volume":"152","clinical-trial-number":[{"clinical-trial-number":"nct03048240","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Maximilien","family":"Vermandel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri-Arthur","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Tuleasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Mordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos G.","family":"Hadjipanayis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-9342","authenticated-orcid":false,"given":"Nicolas","family":"Reyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"key":"3718_CR1","unstructured":"Grill J (2007) Glioblastoma. http:\/\/www.orpha.net\/consor4.01\/www\/cgi-bin\/Disease_Search.php?lng=EN&data_id=3752&Disease_Disease_Search_diseaseGroup=glioblastome&Disease_Disease_Search_diseaseType=Pat&Maladie(s)\/groupes%20de%20maladies=Glioblastome&title=Glioblastome&search=Disease_Search_Simple"},{"issue":"4","key":"3718_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ncl.2007.07.002","volume":"25","author":"JL Fisher","year":"2007","unstructured":"Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25(4):867\u2013890. https:\/\/doi.org\/10.1016\/j.ncl.2007.07.002","journal-title":"Neurol Clin"},{"issue":"4","key":"3718_CR3","first-page":"386","volume":"2","author":"G Iacob","year":"2009","unstructured":"Iacob G, Dinca EB (2009) Current data and strategy in glioblastoma multiforme. J Med Life 2(4):386\u2013393","journal-title":"J Med Life"},{"issue":"7","key":"3718_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro-Oncology 16(7):896\u2013913. https:\/\/doi.org\/10.1093\/neuonc\/nou087","journal-title":"Neuro-Oncology"},{"issue":"10","key":"3718_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"11","key":"3718_CR6","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, Patel AS, Rizk EB, Suki D, Sawaya R, Glantz M (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2(11):1460\u20131469. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1373","journal-title":"JAMA Oncol"},{"issue":"3","key":"3718_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1227\/01.neu.0000317304.31579.17","volume":"62","author":"W Stummer","year":"2008","unstructured":"Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62(3):564\u2013576. https:\/\/doi.org\/10.1227\/01.neu.0000317304.31579.17 (discussion 564-576)","journal-title":"Neurosurgery"},{"issue":"5","key":"3718_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392\u2013401","journal-title":"Lancet Oncol"},{"issue":"3","key":"3718_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11060-019-03109-y","volume":"141","author":"CG Hadjipanayis","year":"2019","unstructured":"Hadjipanayis CG, Stummer W, Sheehan JP (2019) 5-ALA fluorescence-guided surgery of CNS tumors. J Neurooncol 141(3):477\u2013478. https:\/\/doi.org\/10.1007\/s11060-019-03109-y","journal-title":"J Neurooncol"},{"issue":"3","key":"3718_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11060-019-03098-y","volume":"141","author":"CG Hadjipanayis","year":"2019","unstructured":"Hadjipanayis CG, Stummer W (2019) 5-ALA and FDA approval for glioma surgery. J Neurooncol 141(3):479\u2013486. https:\/\/doi.org\/10.1007\/s11060-019-03098-y","journal-title":"J Neurooncol"},{"issue":"1","key":"3718_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-012-0983-4","volume":"111","author":"K Petrecca","year":"2013","unstructured":"Petrecca K, Guiot MC, Panet-Raymond V, Souhami L (2013) Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol 111(1):19\u201323. https:\/\/doi.org\/10.1007\/s11060-012-0983-4","journal-title":"J Neurooncol"},{"issue":"9","key":"3718_CR12","doi-asserted-by":"publisher","first-page":"20523","DOI":"10.3390\/ijms160920523","volume":"16","author":"IO Bacellar","year":"2015","unstructured":"Bacellar IO, Tsubone TM, Pavani C, Baptista MS (2015) Photodynamic efficiency: from molecular photochemistry to cell death. Int J Mol Sci 16(9):20523\u201320559. https:\/\/doi.org\/10.3390\/ijms160920523","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3718_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/neuonc\/nor086","volume":"13","author":"PA Valdes","year":"2011","unstructured":"Valdes PA, Kim A, Brantsch M, Niu C, Moses ZB, Tosteson TD, Wilson BC, Paulsen KD, Roberts DW, Harris BT (2011) delta-Aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. Neuro-Oncology 13(8):846\u2013856. https:\/\/doi.org\/10.1093\/neuonc\/nor086","journal-title":"Neuro-Oncology"},{"issue":"4","key":"3718_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/lsm.22126","volume":"45","author":"A Johansson","year":"2013","unstructured":"Johansson A, Faber F, Kniebuhler G, Stepp H, Sroka R, Egensperger R, Beyer W, Kreth FW (2013) Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis. Lasers Surg Med 45(4):225\u2013234. https:\/\/doi.org\/10.1002\/lsm.22126","journal-title":"Lasers Surg Med"},{"issue":"6","key":"3718_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/j.1751-1097.2010.00799.x","volume":"86","author":"A Johansson","year":"2010","unstructured":"Johansson A, Palte G, Schnell O, Tonn JC, Herms J, Stepp H (2010) 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors. Photochem Photobiol 86(6):1373\u20131378. https:\/\/doi.org\/10.1111\/j.1751-1097.2010.00799.x","journal-title":"Photochem Photobiol"},{"key":"3718_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pdpdt.2018.12.003","volume":"25","author":"M Vermandel","year":"2019","unstructured":"Vermandel M, Quidet M, Vignion-Dewalle A-S, Leroy H-A, Leroux B, Mordon S, Reyns N (2019) Comparison of different treatment schemes in 5-ALA interstitial photodynamic therapy for high-grade glioma in a preclinical model: an MRI study. Photodiagn Photodyn Ther 25:166\u2013176. https:\/\/doi.org\/10.1016\/j.pdpdt.2018.12.003","journal-title":"Photodiagn Photodyn Ther"},{"issue":"5","key":"3718_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/lsm.22744","volume":"50","author":"HA Leroy","year":"2018","unstructured":"Leroy HA, Vermandel M, Leroux B, Duhamel A, Lejeune JP, Mordon S, Reyns N (2018) MRI assessment of treatment delivery for interstitial photodynamic therapy of high-grade glioma in a preclinical model. Lasers Surg Med 50(5):460\u2013468. https:\/\/doi.org\/10.1002\/lsm.22744","journal-title":"Lasers Surg Med"},{"issue":"5","key":"3718_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/lsm.22620","volume":"49","author":"HA Leroy","year":"2017","unstructured":"Leroy HA, Vermandel M, Vignion-Dewalle AS, Leroux B, Maurage CA, Duhamel A, Mordon S, Reyns N (2017) Interstitial photodynamic therapy and glioblastoma: light fractionation in a preclinical model. Lasers Surg Med 49(5):506\u2013515. https:\/\/doi.org\/10.1002\/lsm.22620","journal-title":"Lasers Surg Med"},{"issue":"5","key":"3718_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/lsm.20507","volume":"39","author":"TJ Beck","year":"2007","unstructured":"Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, Baumgartner R (2007) Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 39(5):386\u2013393. https:\/\/doi.org\/10.1002\/lsm.20507","journal-title":"Lasers Surg Med"},{"key":"3718_CR20","doi-asserted-by":"publisher","DOI":"10.3171\/2019.11.JNS192443","author":"S Schipmann","year":"2020","unstructured":"Schipmann S, Muther M, Stogbauer L, Zimmer S, Brokinkel B, Holling M, Grauer O, Suero Molina E, Warneke N, Stummer W (2020) Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control. J Neurosurg. https:\/\/doi.org\/10.3171\/2019.11.JNS192443","journal-title":"J Neurosurg"},{"issue":"1","key":"3718_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11060-007-9497-x","volume":"87","author":"W Stummer","year":"2008","unstructured":"Stummer W, Beck T, Beyer W, Mehrkens JH, Obermeier A, Etminan N, Stepp H, Tonn JC, Baumgartner R, Herms J, Kreth FW (2008) Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report. J Neurooncol 87(1):103\u2013109. https:\/\/doi.org\/10.1007\/s11060-007-9497-x","journal-title":"J Neurooncol"},{"issue":"23","key":"3718_CR22","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318(23):2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718","journal-title":"JAMA"},{"issue":"23","key":"3718_CR23","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z (2015) Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA 314(23):2535\u20132543. https:\/\/doi.org\/10.1001\/jama.2015.16669","journal-title":"JAMA"},{"key":"3718_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3389\/fonc.2019.00620","volume":"9","author":"S Gandhi","year":"2019","unstructured":"Gandhi S, Tayebi Meybodi A, Belykh E, Cavallo C, Zhao X, Syed MP, Borba Moreira L, Lawton MT, Nakaji P, Preul MC (2019) Survival outcomes among patients with high-grade glioma treated with 5-aminolevulinic acid-guided surgery: a systematic review and meta-analysis. Front Oncol 9:620. https:\/\/doi.org\/10.3389\/fonc.2019.00620","journal-title":"Front Oncol"},{"issue":"6","key":"3718_CR25","doi-asserted-by":"publisher","first-page":"E414","DOI":"10.1093\/neuros\/nyy324","volume":"84","author":"C Dupont","year":"2019","unstructured":"Dupont C, Vermandel M, Leroy HA, Quidet M, Lecomte F, Delhem N, Mordon S, Reyns N (2019) INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): study protocol for a phase I clinical trial. Neurosurgery 84(6):E414\u2013E419. https:\/\/doi.org\/10.1093\/neuros\/nyy324","journal-title":"Neurosurgery"},{"key":"3718_CR26","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0261","author":"C Dupont","year":"2017","unstructured":"Dupont C, Mordon S, Deleporte P, Reyns N, Vermandel M (2017) A novel device for intraoperative photodynamic therapy dedicated to glioblastoma treatment. Future Oncol. https:\/\/doi.org\/10.2217\/fon-2017-0261","journal-title":"Future Oncol"},{"issue":"4","key":"3718_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/lsm.20328","volume":"38","author":"A Curnow","year":"2006","unstructured":"Curnow A, MacRobert AJ, Bown SG (2006) Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid. Lasers Surg Med 38(4):325\u2013331. https:\/\/doi.org\/10.1002\/lsm.20328","journal-title":"Lasers Surg Med"},{"issue":"24","key":"3718_CR28","first-page":"6164","volume":"59","author":"S Iinuma","year":"1999","unstructured":"Iinuma S, Schomacker KT, Wagnieres G, Rajadhyaksha M, Bamberg M, Momma T, Hasan T (1999) In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res 59(24):6164\u20136170","journal-title":"Cancer Res"},{"issue":"3","key":"3718_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0967-5868(99)90508-8","volume":"6","author":"SH Tudge","year":"1999","unstructured":"Tudge SH, Kaye AH, Hill JS (1999) Modulation of light delivery in photodynamic therapy of brain tumours. J Clin Neurosci 6(3):227\u2013232. https:\/\/doi.org\/10.1016\/s0967-5868(99)90508-8","journal-title":"J Clin Neurosci"},{"issue":"10","key":"3718_CR30","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"3718_CR31","doi-asserted-by":"publisher","first-page":"iii93","DOI":"10.1093\/annonc\/mdu050","volume":"25","author":"R Stupp","year":"2014","unstructured":"Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G, Group EGW (2014) High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii93\u2013iii101. https:\/\/doi.org\/10.1093\/annonc\/mdu050","journal-title":"Ann Oncol"},{"issue":"9","key":"3718_CR32","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1016\/S1470-2045(14)70011-7","volume":"15","author":"M Weller","year":"2014","unstructured":"Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D, Henriksson R, Balana C, Chinot O, Ram Z, Reifenberger G, Soffietti R, Wick W, European Association for Neuro-Oncology Task Force on Malignant G (2014) EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 15(9):e395-403. https:\/\/doi.org\/10.1016\/S1470-2045(14)70011-7","journal-title":"Lancet Oncol"},{"issue":"21","key":"3718_CR33","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","volume":"35","author":"PY Wen","year":"2017","unstructured":"Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ (2017) Response assessment in neuro-oncology clinical trials. J Clin Oncol 35(21):2439\u20132449. https:\/\/doi.org\/10.1200\/JCO.2017.72.7511","journal-title":"J Clin Oncol"},{"issue":"8","key":"3718_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/00002018-200427080-00010","volume":"27","author":"EG Brown","year":"2004","unstructured":"Brown EG (2004) Using MedDRA: implications for risk management. Drug Saf 27(8):591\u2013602. https:\/\/doi.org\/10.2165\/00002018-200427080-00010","journal-title":"Drug Saf"},{"issue":"12","key":"3718_CR35","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1093\/annonc\/mdt388","volume":"24","author":"FW Kreth","year":"2013","unstructured":"Kreth FW, Thon N, Simon M, Westphal M, Schackert G, Nikkhah G, Hentschel B, Reifenberger G, Pietsch T, Weller M, Tonn JC, German Glioma N (2013) Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. Ann Oncol 24(12):3117\u20133123. https:\/\/doi.org\/10.1093\/annonc\/mdt388","journal-title":"Ann Oncol"},{"issue":"11","key":"3718_CR36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s12094-016-1497-x","volume":"18","author":"PD Delgado-Lopez","year":"2016","unstructured":"Delgado-Lopez PD, Corrales-Garcia EM (2016) Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol 18(11):1062\u20131071. https:\/\/doi.org\/10.1007\/s12094-016-1497-x","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"3718_CR37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1470-2045(11)70196-6","volume":"12","author":"C Senft","year":"2011","unstructured":"Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12(11):997\u20131003. https:\/\/doi.org\/10.1016\/S1470-2045(11)70196-6","journal-title":"Lancet Oncol"},{"issue":"5","key":"3718_CR38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1751-1097.1987.tb04872.x","volume":"46","author":"H Kostron","year":"1987","unstructured":"Kostron H, Weiser G, Fritsch E, Grunert V (1987) Photodynamic therapy of malignant brain tumors: clinical and neuropathological results. Photochem Photobiol 46(5):937\u2013943. https:\/\/doi.org\/10.1111\/j.1751-1097.1987.tb04872.x","journal-title":"Photochem Photobiol"},{"issue":"2","key":"3718_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/02688698808992675","volume":"2","author":"H Kostron","year":"1988","unstructured":"Kostron H, Fritsch E, Grunert V (1988) Photodynamic therapy of malignant brain tumours: a phase I\/II trial. Br J Neurosurg 2(2):241\u2013248. https:\/\/doi.org\/10.3109\/02688698808992675","journal-title":"Br J Neurosurg"},{"key":"3718_CR40","doi-asserted-by":"crossref","unstructured":"Kostron H, Hochleitner B, Obwegeser A, Seiwald M (1995) Clinical and experimental results of photodynamic therapy in neurosurgery, vol 2371. Fifth international photodynamic association biennial meeting. SPIE","DOI":"10.1117\/12.203437"},{"issue":"2","key":"3718_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/neuonc\/noy132","volume":"21","author":"A Mansouri","year":"2019","unstructured":"Mansouri A, Hachem LD, Mansouri S, Nassiri F, Laperriere NJ, Xia D, Lindeman NI, Wen PY, Chakravarti A, Mehta MP, Hegi ME, Stupp R, Aldape KD, Zadeh G (2019) MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges. Neuro-Oncology 21(2):167\u2013178. https:\/\/doi.org\/10.1093\/neuonc\/noy132","journal-title":"Neuro-Oncology"},{"issue":"8956","key":"3718_CR42","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/s0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Polym Brain Tumor Treat Gr Lancet 345(8956):1008\u20131012. https:\/\/doi.org\/10.1016\/s0140-6736(95)90755-6","journal-title":"Polym Brain Tumor Treat Gr Lancet"},{"issue":"2","key":"3718_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF01060217","volume":"26","author":"H Brem","year":"1995","unstructured":"Brem H, Ewend MG, Piantadosi S, Greenhoot J, Burger PC, Sisti M (1995) The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. J Neurooncol 26(2):111\u2013123. https:\/\/doi.org\/10.1007\/BF01060217","journal-title":"J Neurooncol"},{"issue":"29","key":"3718_CR44","doi-asserted-by":"publisher","first-page":"11751","DOI":"10.1073\/pnas.1304504110","volume":"110","author":"J Zhou","year":"2013","unstructured":"Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng MQ, Duong N, Schafbauer T, Huttner AJ, Huang Y, Carson RE, Zhang Y, Sullivan DJ Jr, Piepmeier JM, Saltzman WM (2013) Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci USA 110(29):11751\u201311756. https:\/\/doi.org\/10.1073\/pnas.1304504110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"3718_CR45","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.2217\/fon-2017-0261","volume":"13","author":"C Dupont","year":"2017","unstructured":"Dupont C, Mordon S, Deleporte P, Reyns N, Vermandel M (2017) A novel device for intraoperative photodynamic therapy dedicated to glioblastoma treatment. Future Oncol 13(27):2441\u20132454. https:\/\/doi.org\/10.2217\/fon-2017-0261","journal-title":"Future Oncol"},{"issue":"9","key":"3718_CR46","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/lsm.21135","volume":"43","author":"MS Mathews","year":"2011","unstructured":"Mathews MS, Chighvinadze D, Gach HM, Uzal FA, Madsen SJ, Hirschberg H (2011) Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain. Lasers Surg Med 43(9):892\u2013900. https:\/\/doi.org\/10.1002\/lsm.21135","journal-title":"Lasers Surg Med"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03718-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03718-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03718-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:30:15Z","timestamp":1628591415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03718-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3718"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03718-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"16 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Vermandel, C. Dupont, S. Mordon and N. Reyns are co-founders of Hemerion Therapeutics SAS, Lille, France. Constantinos Hadjipanayis is a consultant for NX Development Corporation (NXDC) and Synaptive Medical Inc. He receives royalties from the sale of Gleolan\u00ae (5-ALA) which is marketed by NXDC. Gleolan\u00ae is an optical imaging agent approved in the United States for the visualization of malignant tissue during glioma surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All subjects signed a written informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All subject authorized the publication anonymously of their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"All procedures performed in studies were in accordance with the ethical standards of the National Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The French National Agency for Medicine and Health Product Safety (ANSM) as well as the French National Ethics Committee approved this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}